ZYBERNO
Stock Report
Updated Aug 31, 2026

MindWalk Holdings Corp. (HYFT)

Healthcare • NASDAQ

$1.34

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
23.0/100
POOR BUSINESS
MindWalk Holdings Corp. (HYFT) scores 23/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-53.5%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (0.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

MindWalk Holdings Corp. (HYFT) stock report — Zyberno Score 23/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.34
Market Cap:$62.59M

Valuation Multiples (3)

P/B Ratio:3.72x
P/S Ratio:3.90x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$54.91M
Ev Ebitda Ratio:14.98x

Price Action & Momentum (3)

Momentum Percentile:81 / 100
% of 52-Week High:44.8%
B. Profitability Assessment

Margin Analysis (2)

Net Margin Ttm:-56.1%
Ebitda Margin:22.9%

TTM Performance (2)

Gross Margin Ttm:56.5%
Net Margin Ttm:-56.1%

Yield Metrics (2)

Earnings Yield:-$115.83
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-17.8%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.74x
Quick Ratio:3.64x
Cash Ratio:2.15x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:0.00x

Coverage Ratios (2)

Interest Coverage Ratio:0.00x
Times Interest Earned:0.00

Capital Structure (4)

Working Capital:9,813,431.22
Cash And Cash Equivalents:7,682,026.57
Long Term Debt:$0.00
Net Debt:-$7.68M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $16.04M
Linear Growth: -17.8%
📊 Click to view full HYFT Revenue analysis & methodology →
Cost Of Revenue Ttm:$6.98M

Profitability Breakdown (2)

Gross profit TTM: $9.05M
Linear Growth: -8.4%
📊 Click to view full HYFT Gross Profit analysis & methodology →
$0.00

Bottom Line Performance (3)

-$9.00M
Income Before Tax:$0.00
Ebitda Ttm:3,665,531.91

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:0.00
Sga Expense:0.00
Income Tax Expense:-$738.23K
Interest Expense:141,666.51

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:0.0%
Ebitda Margin:22.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$16.36M
Current Assets:$13.39M
Ppe Net:2,861,805.84
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:-454,898.99
Current Liabilities:3,580,816.76
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$16.82M
Retained Earnings:$0.00
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:348,827.08
Accounts Payable:0.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$4.56M-$5.13M

Investment Activities (1)

Investing Cash Flow:-$422.86K

Financing Activities (3)

Financing Cash Flow:-$264.11K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:3,665,531.91
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.61
-$1.61
Earnings Per Share Ttm:-$0.19

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.34
Operating Cash Flow Per Share:-$0.10

Book Value & Capital (2)

Book Value Per Share:$0.36
Cash Per Share:0.16

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.98x
Working Capital Turnover Ttm:1.63x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:20.02x
Days Inventory Outstanding Ttm:18.23

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:18.23
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-17.8%

Other Growth Rates (1)

Gross Profit Growth Rate (Linear):-8.4%
C. Company Profile & Context

Corporate Information (6)

Symbol:HYFT
Company Name:MindWalk Holdings Corp.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:46.71M
Shares Outstanding Basic:0
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 21:48:16 UTC
Data Timestamp:2026-08-20T00:13:29.508878
Scroll to Top